drugset / Trial / NCT05840913

Different Volumes of Articaine for Inferior Alveolar Nerve Block in Irreversible Pulpitis

NCT05840913

Phase 2 Completed 78 enrolled Armed Forces Institute of Dentistry, Pakistan
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a randomized controlled trial comparing the anaesthetic efficacy of 1.8 and 3.6 mL of Articaine for inferior alveolar nerve block when treating mandibular molars with Irreversible Pulpitis

Timeline

Start
2023-12-01
Primary completion
2024-07-31
Completion
2024-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Articaine Other / unclassified 1.8 ml Other
Subject Articaine Other / unclassified 3.6 ml Other
Background Epinephrine Other / unclassified Other

Indications